Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel · Delayed Price · Currency is ILS · Price in ILA 372.00
+0.60 (0.16%)
Aug 21, 2025, 5:24 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 83.77 million as of August 22, 2025. Its market cap has decreased by -17.58% in one year.
Market Cap
83.77M
Enterprise Value
16.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
372.00
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 83.77M, a decrease of -77.24%. That is a compound annual growth rate of -20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 83.33M | -11.08% |
| Dec 31, 2024 | 93.71M | -48.18% |
| Dec 29, 2023 | 180.84M | -29.06% |
| Dec 30, 2022 | 254.92M | -28.46% |
| Dec 31, 2021 | 356.33M | -8.65% |
| Dec 31, 2020 | 390.07M | 30.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.28B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 1.42B |
| Bait Bakfar | 1.06B |
| SofWave Medical | 1.05B |
| BrainsWay | 937.53M |
| Novolog (Pharm-Up 1966) | 735.66M |
| Ilex Medical | 677.33M |